LivingGLP1
Study S002811

A Single-center, Randomized, Double-blind, Placebo-controlled, Crossover Study to Assess the Effect of Multiple Subcutaneous Injections of SHR20004 in Healthy Subjects on Gastric Emptying

Registration

Registration
NCT06137469
Study type
INTERVENTIONAL
Allocation
RANDOMIZED
Phase
PHASE1
Masking
QUADRUPLE
Status
COMPLETED
Enrollment
28
Start
2023-12-26
Primary completion
2024-03-16
Lead sponsor
Jiangsu HengRui Medicine Co., Ltd.
Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG:Acetaminophen/SHR20004; DRUG:Acetaminophen/Placebo
Results posted
FALSE
Individual participant data sharing
UNDECIDED

Registered primary outcomes

  • Pharmacokinetics parameters of acetaminophen after a single dose of 1.0 g was measured after administration of the standardized meal.:(AUC0-300min) [Based on pre-dose to 300 min post-dose sampling times on Day 1 and Day 31]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.